OMEROS CORPORATION PURCHASE AGREEMENTPurchase Agreement • November 15th, 2018 • Omeros Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 15th, 2018 Company Industry Jurisdiction
Gannett Co., Inc. PURCHASE AGREEMENTPurchase Agreement • April 9th, 2018 • Gannett Co., Inc. • Newspapers: publishing or publishing & printing • New York
Contract Type FiledApril 9th, 2018 Company Industry Jurisdiction
NEUROCRINE BIOSCIENCES, INC. PURCHASE AGREEMENTPurchase Agreement • May 2nd, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 2nd, 2017 Company Industry Jurisdiction
INCONTACT, INC. 2.50% Convertible Senior Notes due 2022 PURCHASE AGREEMENTPurchase Agreement • March 30th, 2015 • inContact, Inc. • Services-prepackaged software • New York
Contract Type FiledMarch 30th, 2015 Company Industry Jurisdiction
Aegerion Pharmaceuticals, Inc. PURCHASE AGREEMENTPurchase Agreement • August 12th, 2014 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 12th, 2014 Company Industry Jurisdiction
SPECTRUM PHARMACEUTICALS, INC. 2.75% Convertible Senior Notes due 2018 PURCHASE AGREEMENTPurchase Agreement • December 23rd, 2013 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 23rd, 2013 Company Industry JurisdictionThis opinion is provided to you at the request of Spectrum Pharmaceuticals, Inc. (the “Company”), pursuant to Section [7(a)(vi)] of the Purchase Agreement, dated December [—], 2013 (the “Purchase Agreement”), between Jefferies LLC and RBC Capital Markets, LLC, as representative of the several Initial Purchasers listed in Schedule I thereto (collectively, the “Initial Purchasers”) and the Company. Capitalized terms below that are not otherwise defined shall have the meaning ascribed to them in the Purchase Agreement.